Literature DB >> 26667151

Effects of aerobic interval training on measures of anxiety, depression and quality of life in patients with ischaemic heart failure and an implantable cardioverter defibrillator: A prospective non-randomized trial.

Kjetil Isaksen1, Peter Scott Munk, Rune Giske, Alf Inge Larsen.   

Abstract

OBJECTIVE: To evaluate the short- and long-term effects of aerobic interval training on quality of life and on symptoms of anxiety and depression among patients with ischaemic heart failure and an implantable cardioverter defibrillator.
DESIGN: Prospective, non-randomized controlled study.
SUBJECTS: Patients with ischaemic heart failure and an implantable cardioverter defibrillator, willing to undergo an aerobic interval training programme. A total of 31 patients were enrolled (19 were assigned to the aerobic interval training group and 12 to the control group).
METHODS: The aerobic interval training group performed a 12-week exercise training programme. All patients were evaluated with the Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale (HADS) and the International Physical Activity Questionnaire at baseline, after 12 weeks and at 2 years.
RESULTS: The aerobic interval training group showed significant improvements in several SF-36 subscores at 12 weeks. There was an unadjusted significant reduction in the HADS depression (HADS-D) score. At follow-up, results in the aero-bic interval training group moved towards baseline or remained stable, whereas in the control group HADS-D scores and some SF-36 subscores deteriorated.
CONCLUSION: Participation in a 12-week aerobic interval training programme resulted in significant improvements in several measures of quality of life and the unadjusted HADS-D score in patients with ischaemic heart failure with an implantable cardioverter defibrillator. At follow-up there was significantly less sedentary activity in the aerobic interval training group, while psychometric measures were no longer significantly different from baseline.

Entities:  

Mesh:

Year:  2016        PMID: 26667151     DOI: 10.2340/16501977-2043

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  7 in total

1.  Exercise Training Improved Longitudinal Intrinsic Left Ventricle Function in Heart Failure with Preserved Ejection Fraction.

Authors:  Anwar Santoso; Sidhi Laksono Purwowiyoto; Budhi Setianto Purwowiyoto; Amiliana Mardiana Soesanto
Journal:  Int J Angiol       Date:  2019-01-08

Review 2.  Heart-brain Interactions in Heart Failure.

Authors:  Nadja Scherbakov; Wolfram Doehner
Journal:  Card Fail Rev       Date:  2018-08

3.  Aerobic Exercise Effects on Quality of Life and Psychological Distress After an Implantable Cardioverter Defibrillator.

Authors:  Cynthia M Dougherty; Robert L Burr; Peter J Kudenchuk; Robb W Glenny
Journal:  J Cardiopulm Rehabil Prev       Date:  2020-03       Impact factor: 3.646

Review 4.  A Systematic Review and Meta-Analysis of the Effectiveness of High-Intensity Interval Training in People with Cardiovascular Disease at Improving Depression and Anxiety.

Authors:  Tingting Gu; Pengli Hao; Ping Chen; Yi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-06       Impact factor: 2.650

5.  Efficacy of Vitamin D Supplementation in Addition to Aerobic Exercise Training in Obese Women with Perceived Myalgia: A Single-Blinded Randomized Controlled Clinical Trial.

Authors:  Heba Ahmed Ali Abdeen; David Rodriguez-Sanz; Mahmoud Ewidea; Dina Mohamed Ali Al-Hamaky; Marwa Abd El-Rahman Mohamed; Ahmed Ebrahim Elerian
Journal:  Nutrients       Date:  2021-05-27       Impact factor: 5.717

Review 6.  High-Intensity Interval Training in Older Adults: a Scoping Review.

Authors:  Catherine F S Marriott; Andrea F M Petrella; Emily C S Marriott; Narlon C Boa Sorte Silva; Robert J Petrella
Journal:  Sports Med Open       Date:  2021-07-19

7.  Anxiety and depression predicted quality of life among patients with heart failure.

Authors:  Mohannad Eid AbuRuz
Journal:  J Multidiscip Healthc       Date:  2018-07-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.